Experimental study suggests bone-marrow grafts show promise for some sufferers of low-back pain

A new study suggests that the type of bio-cellular grafts increasingly used by surgeons to repair damaged tissue may be useful for treating low-back pain (LBP). However, not all sufferers responded equally to the novel therapy. Results reported today at the 29th Annual Meeting of the American Academy of Pain Medicine ranged from complete pain relief to no improvement.

The procedure involved injecting a concentrated form of bone-marrow cellular aspirate into lumbar discs in patients with clinical and objective evidence of . The results were reported in a poster authored by researchers from the Columbia Interventional Center in Columbia, Mo., and the Bluetail Medical Group in Chesterfield, Mo.

"The results of our case review are encouraging," said Donald J. Meyer, MD, PhD, the study's primary author. "Currently, when measures fail, are limited for individuals with back pain due to disc degeneration. Many resort to disc surgery or with mediocre results. Our goal is to help develop a safe, natural method to boost the body's own capacity to heal discogenic pain."

The practice of using autologous grafts, in which material is transferred from within the same individual's body, has evolved beyond the simple use of platelet-rich plasma to encompass cellular bone-marrow concentrate and cells drawn from body fat, the study authors explained. Intrigued by the technique's possibilities in treating LBP, the team retrospectively examined data for 22 consecutive patients treated at Columbia Interventional Pain Center in Columbia, Mo., over 18 months. Patients had LBP lasting an average of 4 years along with evidence confirming changes via CT scan or MRI. Some patients also complained of leg pain.

Patients were informed of the study's experimental nature and gave informed consent. During the procedure, investigators harvested 60 cc iliac bone-marrow aspirate and concentrated it in a centrifuge to obtain bone-marrow aspirate cellular concentrate (BMAC). They then injected BMAC into each affected lumbar disc annulus using a 22-gauge Chiba needle under fluoroscopy. This was followed by the injection of an additional small amount of BMAC immediately external to the annulus. A maximum of 2 discs were treated.

At 5-24 months following treatment, patients reported changes in back pain ranging from complete pain relief to no improvement. No patient reported a worsening of pain, and no complications occurred. All subjects who experienced pain relief also reported significant improvement in activity tolerance or a reduction in pain medication use, or both.

A future prospective study is warranted, the authors concluded, to examine whether biologic autograft treatment may provide a safe and effective therapy for lumbar discogenic pain.

Provided by American Academy of Pain Medicine

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Pattern of disc degeneration impacts low back pain

Apr 12, 2012

(HealthDay) -- Contiguous, multilevel disc degeneration (CMDD) is associated with increased likelihood of low back pain (LBP) and pain severity compared with skipped level disc degeneration (SLDD), according ...

Upper lumbar disc space related to hip pain

Dec 21, 2012

(HealthDay)—Disc space narrowing at disc levels L1/L2 and L2/L3, visible on lumbar radiographs, may help to identify hip pain patients whose pain originates in the lumbar spine, according to research published ...

Spine patients who quit smoking report diminished pain

Mar 19, 2013

Smoking is a known risk factor for back pain and disc disease. In a new study presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers reviewed smoking cessation rates ...

Recommended for you

Second bird flu case confirmed in Canada

14 hours ago

The husband of a Canadian who was diagnosed earlier this week with bird flu after returning from a trip to China has also tested positive for the virus, health officials said Friday.

What exactly is coronavirus?

21 hours ago

The conflicts in Syria and Iraq are straining public health systems and public health efforts meant to prevent and detect the spread of infectious diseases. This is generating a "perfect storm" of conditions for outbreaks. Among the infections raising concern is Middle East Respiratory Syndrome, caused by a type of coronavirus, which emerged in 2012. ...

Scientists find Ebola virus is mutating

21 hours ago

(Medical Xpress)—Researchers working at Institut Pasteur in France have found that the Ebola virus is mutating "a lot" causing concern in the African countries where the virus has killed over eight thous ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.